Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
27.5M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
14.1K
-
Shares change
-
+14.1K
-
Total reported value, excl. options
-
$158K
-
Value change
-
+$158K
-
Number of buys
-
1
-
Price
-
$11.22
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q4 2023
1 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value as of Q4 2023.
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.1K shares
of 27.5M outstanding shares and own 0.05% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4.08M shares), Sonic GP LLC (2.41M shares), Solas Capital Management, LLC (1.38M shares), Avoro Capital Advisors LLC (1.2M shares), VANGUARD GROUP INC (1.14M shares), DG Capital Management, LLC (1.08M shares), BlackRock Inc. (935K shares), HARBERT FUND ADVISORS, INC. (467K shares), AIGH Capital Management LLC (329K shares), and GENDELL JEFFREY L (282K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.